Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Cancers
|
March 25, 2022
Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives
Asad Ullah, Jaffar Khan, Abdul Waheed, et al.
Cell Reports
|
October 21, 2020
SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures
Camille Tlemsani, Lorinc Pongor, Fathi Elloumi, et al.
Nature Structural & Molecular Biology
|
October 23, 2025
Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification
Rebecca M Starble, Eric G Sun, Rana Gbyli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 8, 2019
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
Anish Thomas, Rasa Vilimas, Christopher Trindade, et al.
Cancer Cell
|
August 13, 2021
Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
Kosuke Tanaka, Helena A Yu, Shaoyuan Yang, et al.
Cell Reports
|
March 7, 2019
APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors
Nitin Roper, Shaojian Gao, Tapan K Maity, et al.
Cancer Research Communications
|
August 20, 2024
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples
Yasuhiro Arakawa, Fathi Elloumi, Sudhir Varma, et al.
Cancers
|
July 20, 2021
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
Chul Kim, Liqiang Xi, Constance M Cultraro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
Min Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
Cancer Research Communications
|
March 7, 2024
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
Yasuhiro Arakawa, Ukhyun Jo, Suresh Kumar, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Cancers
|
March 25, 2022
Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives
Asad Ullah, Jaffar Khan, Abdul Waheed, et al.
Cell Reports
|
October 21, 2020
SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures
Camille Tlemsani, Lorinc Pongor, Fathi Elloumi, et al.
Nature Structural & Molecular Biology
|
October 23, 2025
Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification
Rebecca M Starble, Eric G Sun, Rana Gbyli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 8, 2019
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
Anish Thomas, Rasa Vilimas, Christopher Trindade, et al.
Cancer Cell
|
August 13, 2021
Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
Kosuke Tanaka, Helena A Yu, Shaoyuan Yang, et al.
Cell Reports
|
March 7, 2019
APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors
Nitin Roper, Shaojian Gao, Tapan K Maity, et al.
Cancer Research Communications
|
August 20, 2024
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples
Yasuhiro Arakawa, Fathi Elloumi, Sudhir Varma, et al.
Cancers
|
July 20, 2021
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
Chul Kim, Liqiang Xi, Constance M Cultraro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
Min Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
Cancer Research Communications
|
March 7, 2024
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
Yasuhiro Arakawa, Ukhyun Jo, Suresh Kumar, et al.
Page
of 5